News
Biocon and Mylan get U.S. FDA approval for insulin glargine injection
Mylan N.V. and Biocon Ltd. announced that the U.S. FDA has approved the New Drug Application (NDA) for Semglee (insulin glargine injection), in vial and pre-filled pen presentations, to control high blood sugar in adults with type 2 diabetes...
News
Lonza Capsules and Health Ingredients introduces HPMC double-blinded capsules for clinical trials
A global capsule and equipment developer and manufacturer, Lonza has introduced an enhanced product line aimed at tackling concerns around bias during blinded clinical trials.
Capsugel® DBcaps® double-blinded capsules are designed to be used as an over-encapsulation tool during clinical...
News
German Federal Government invests 300 Million Euros in CureVac
The German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp, SAP co-founder and co-founder of the investment company dievini Hopp BioTech holding GmbH & Co. KG, announced that the Federal Republic of Germany will invest...
News
Naari completes acquisition of ANDAs from Intas Pharmaceuticals
Naari Pharma Private Limited, through its wholly owned subsidiary Naari Pte, has entered into a definitive asset purchase agreement to acquire 10 Abbreviated New Drug Applications (ANDAs) for the U.S. market from Intas Pharmaceuticals Ltd.
The portfolio acquired comprises eight...
News
DHL Global Forwarding combats Covid-19 with charter Flights and Trains
Difficult times require flexible and pragmatic action - especially when it comes to safeguarding supply chains. DHL Global Forwarding, Deutsche Post DHL Group’s air and ocean freight specialist, is deploying its many years of expertise to meet rapidly growing...
News
UK Pharma Firm Wins US Backing For Antibody-Based COVID-19 Treatment
AstraZeneca has secured support from the US government to advance the development of antibody-based COVID-19 treatments as the British drugmaker ramps up efforts beyond its potential vaccine to combat the global health crisis.
The company said on Tuesday it had...
News
Novadoz Pharmaceuticals FDA Approvals of Oseltamivir and Dofetilide Continues the Company’s Rise in the Generic Market
Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, located in Hyderabad India, recently received FDA approval for their generic versions of Oseltamivir Phosphate Capsules and Dofetilide Capsules.
The company was notified earlier this year, that Dofetilide...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read